FORA Capital LLC Purchases New Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

FORA Capital LLC acquired a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 26,567 shares of the medical instruments supplier’s stock, valued at approximately $719,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. UMB Bank n.a. grew its stake in DENTSPLY SIRONA by 430.3% during the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock worth $25,000 after buying an additional 753 shares during the last quarter. Capital Performance Advisors LLP acquired a new stake in shares of DENTSPLY SIRONA in the third quarter valued at approximately $27,000. LRI Investments LLC grew its position in shares of DENTSPLY SIRONA by 82.7% during the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock worth $31,000 after acquiring an additional 564 shares during the last quarter. Rothschild Investment LLC purchased a new stake in DENTSPLY SIRONA in the 2nd quarter valued at $32,000. Finally, Kennebec Savings Bank acquired a new stake in DENTSPLY SIRONA during the 3rd quarter worth $35,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

Analyst Upgrades and Downgrades

XRAY has been the subject of a number of research reports. Leerink Partners cut shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Thursday, November 7th. StockNews.com cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Tuesday, November 19th. Leerink Partnrs downgraded DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 7th. Robert W. Baird decreased their price target on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a report on Friday, November 8th. Finally, Needham & Company LLC lowered their price objective on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a research report on Friday, October 25th. Seven equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $29.50.

View Our Latest Research Report on DENTSPLY SIRONA

DENTSPLY SIRONA Trading Up 2.3 %

DENTSPLY SIRONA stock opened at $19.64 on Friday. DENTSPLY SIRONA Inc. has a one year low of $17.21 and a one year high of $37.60. The business has a fifty day moving average of $22.83 and a two-hundred day moving average of $24.89. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last released its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, topping analysts’ consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The firm had revenue of $951.00 million for the quarter, compared to the consensus estimate of $939.10 million. During the same quarter in the previous year, the firm earned $0.49 earnings per share. The firm’s revenue was up .4% on a year-over-year basis. Research analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Featured Stories

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.